Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel patent CN118146201A enables high-yield Tergoprazan production with reduced costs and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN107540575A reveals a cost-effective route for Sitagliptin intermediates. This report analyzes supply chain advantages and high-purity manufacturing capabilities for global buyers.
Novel aqueous hydrolysis patent CN110357773A enables cost reduction in pharma intermediates manufacturing with high purity and scalable supply chain reliability for global buyers.
Novel solvent-free synthesis of anticancer intermediate CN102911177A. High yield, green chemistry, scalable for API manufacturing.
Novel sulfur ylide method for Formula 1 improves safety and yield for Paxlovid manufacturing, offering a robust alternative to hazardous phosphorus routes.
Advanced synthesis of Betrixaban intermediate via patent CN107868039A. Offers cost reduction in pharmaceutical intermediates manufacturing and reliable supply chain solutions.
Patent CN115784968A reveals a safer sulfur ylide route for Formula 1, offering high yields and scalable manufacturing for reliable pharmaceutical intermediate suppliers.
Patent CN107176975A details solid-state Gonadorelin synthesis ensuring high purity and scalable manufacturing for reliable pharmaceutical intermediate supply chains.
Novel organosilane reduction method for Ticagrelor intermediate ensures high purity and supply chain stability for global pharmaceutical manufacturing partners.
Novel palladium catalyzed route ensures high purity phenanthridinone intermediates with streamlined processing for reliable pharmaceutical supply chains and cost efficiency.
Patent CN108440447A reveals a catalyst-free synthesis route for high-purity pharmaceutical intermediates, offering significant supply chain and cost advantages for global buyers.
Patent CN100453545C details a high-yield route for 7-ACP using mixed solvents to eliminate isomers, offering superior purity for antibiotic manufacturers.
Patent CN103183686B reveals high-yield synthesis for cephamycin intermediates. Enhance supply chain reliability and reduce manufacturing costs with scalable methods.
Patent CN101284832A reveals a novel 9-epiquinine catalyzed route for (4S,5R)-half ester, offering high stereoselectivity and cost-effective manufacturing for Vitamin H supply chains.
Novel organocatalytic synthesis offers high stereoselectivity and yield for pharmaceutical intermediates, ensuring scalable supply chain solutions.
Novel 3-step route for Saxagliptin intermediate manufacturing reduces cost and improves purity for pharmaceutical supply chains.
Patent CN110724148B details a novel 1,3-dipolar cycloaddition route for antitumor spiro-indazole derivatives, offering scalable manufacturing and cost-effective API intermediate production.
Patent CN114539342B reveals an industrial method for TUDCA using alcohol solvents to reduce impurities, offering cost-effective pharma intermediate manufacturing.
Novel route for polycyclic lactones via Sonogashira coupling. Reduces cost in pharmaceutical intermediate manufacturing with high purity.
Novel catalyst-free synthesis of 1-phenyl-5-mercapto tetrazole via sulfonate intermediates. Achieves >90% yield, reducing toxicity and cost for statin manufacturing.